The Priority Review

Tag

Pharmobedient Consulting LLC

1 story

Stories

  1. Regulation

    FDA determines BROMFED-DM syrup not withdrawn for safety or effectiveness

    In a notice, the FDA said that BROMFED-DM (brompheniramine maleate, dextromethorphan hydrobromide, pseudoephedrine hydrochloride) syrup, 2 mg/5 mL; 10 mg/5 mL; 30 mg/5 mL, was not withdrawn from sale for reasons of safety or effectiveness. The AGENCY will continue to list the product in the Discontinued Drug Product List and may approve additional ANDAs that meet regulatory requirements.